September 28, 2026
Breaking
Business

Sun Pharma bags rights to $3.7 billion cholesterol drug market globally

admin1 min read

Sun Pharma will commercialise and manufacture LIB Therapeutics’ once-monthly cholesterol drug outside the US and China after its EU approval

The post Sun Pharma bags rights to $3.7 billion cholesterol drug market globally appeared first on Home Page.

Leave a Comment

Your email address will not be published. Required fields are marked *